ConductScience.org, home

Gene · 6530

Papers3,539

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

TitleJournalYearPMIDFound bySource
18F-meta-fluorobenzylguanidine as a New PET Tracer in Imaging Neuroblastoma.PET Clin202641436335PubTator, text miningPubMed
Integrating [11C]methylreboxetine PET and MRI to map in vivo norepinephrine transporter distribution: A proof-of-concept study of noradrenergic vulnerability in neurodegeneration.Nucl Med Biol202641297218PubTator, text miningPubMed
Drug-Induced Raynaud's Phenomenon and Underlying Mechanism: A Disproportionality Analysis From the World Health Organization Pharmacovigilance Database.Arthritis Rheumatol202641261736PubTator, text miningPubMed
Effects of Extended-Release Methylphenidate on Dopamine and Norepinephrine Transporters in Adults With Attention-Deficit/Hyperactivity Disorder: A Longitudinal Dual-Tracer PET Study.Psychiatry Clin Neurosci202641128391PubTator, text miningPubMed
Glucose metabolism alterations and Aβ deposition in AD and FTD are related to the distribution of neurotransmitter systems.Eur J Nucl Med Mol Imaging202640773016PubTator, text miningPubMed
Noradrenergic excitation of astrocytes supports cognitive reserve.Neural Regen Res202640587240PubTator, text miningPubMed
Localization of brain networks activated by acupuncture at anatomically adjacent acupoints in healthy participants: neuroimaging evidence and implications for migraine and stroke.Front Neurosci202541601526PubTator, text miningPubMed
Stimulant medications affect arousal and reward, not attention networks.Cell202541448140PubTator, text miningPubMed
Morphometric Latent Factors in Autism and Their Association with Receptor Profiles and Behavior.bioRxiv202541427383PubTator, text miningPubMed
Corrigendum to "Apixaban kinetics could be influenced by sex, cytochrome P450 enzymes and SLC6A2 transporter" [Biomed. Pharmacother. 193 (December) (2025) 118732].Biomed Pharmacother202541241576PubTator, text miningPubMed
Experimental study on the treatment of norepinephrine transporter-overexpressing pheochromocytomas and paragangliomas: a synthetic lethality strategy combining 131I-MIBG with PARP inhibitors.Front Oncol202541234725PubTator, text miningPubMed
Heterogeneity of brain functional connectivity, transcriptome, and neurotransmitter profiles in major depressive disorder.Psychol Med202541220307PubTator, text miningPubMed
The Potential Future Role of Genetic Markers, Neurophysiological Insights, and AI Innovations in Personalized Attention-Deficit/Hyperactivity Disorder (ADHD) Management.Cureus202541200630PubTator, text miningPubMed
Prolintane analogs as hybrid monoamine transporter ligands: Structural determinants and species differences.J Biol Chem202541197716PubTator, text miningPubMed
Apixaban kinetics could be influenced by sex, cytochrome P450 enzymes and SLC6A2 transporter.Biomed Pharmacother202541187610PubTator, text miningPubMed
Release and Reuptake Sites for Norepinephrine Are Differently Distributed Across Layers of the Primary Visual Cortex in Macaque Monkeys.J Comp Neurol202541185625PubTator, text miningPubMed
Deciphering the structural impact of norepinephrine analog radiopharmaceuticals on organic cation transporter affinity.Biomed Pharmacother202541172956PubTator, text miningPubMed
Brain Network Signature of Autoscopic Phenomena in Humans.CNS Neurosci Ther202541163214PubTator, text miningPubMed
Pharmacogenomics in Orofacial Clefts Care: Insights from Whole-Genome Sequencing of Case-Parents Trios.J Pers Med202541149818PubTator, text miningPubMed
Unveiling conformation-selective regulation of the norepinephrine transporter.Cell202541138730PubTator, text miningPubMed

gene-search-2026-11-11-0.2.0

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/6530/papers?page=4